Home
NUVB
NUVB News

Latest Nuvation Bio Inc. (NUVB) News on June 25, 2025

MT Newswires

13 hours ago

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Powell Testimony

MT Newswires

14 hours ago

Nuvation Bio Says Taletrectinib Added as Preferred Agent in National Comprehensive Cancer Network for Lung Cancer

Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI™) as Preferred Option to Clinical Practice Guidelines in Oncology for Advanced ROS1+ Non-Small Cell Lung Cancers

Business Wire

15 hours ago

Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI™) as Preferred Option to Clinical Practice Guidelines in Oncology for Advanced ROS1+ Non-Small Cell Lung Cancers

Are These 2 'Strong Buy' Rated Growth Stocks Buys Right Now?

Barchart

4 days ago

Are These 2 'Strong Buy' Rated Growth Stocks Buys Right Now?

Founder of Nuvation Bio David Hung Buys More Stock

Simply Wall St.

5 days ago

Founder of Nuvation Bio David Hung Buys More Stock

Argus Research

5 days ago

Daily – Vickers Top Buyers & Sellers for 06/20/2025

MT Newswires

8 days ago

RBC Cuts Price Target on Nuvation Bio to $6 From $10, Keeps Outperform, Speculative Risk

MT Newswires

13 days ago

Nuvation Bio Wins US FDA Approval for Non-Small Cell Lung Cancer Drug Ibtrozi

U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer

Business Wire

13 days ago

U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer

FDA clears Nuvation lung cancer drug, setting up battle with Bristol Myers and Roche

BioPharma Dive

14 days ago

FDA clears Nuvation lung cancer drug, setting up battle with Bristol Myers and Roche

Business Wire

a month ago

Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting

Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025

Business Wire

a month ago

Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025

Nuvation Bio to Participate in Upcoming Investor Conferences

Business Wire

a month ago

Nuvation Bio to Participate in Upcoming Investor Conferences

GuruFocus.com

2 months ago

Nuvation Bio Inc (NUVB) Q1 2025 Earnings Call Highlights: Promising Developments and Strategic Moves

Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential

Insider Monkey

2 months ago

Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential

Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates

Zacks

2 months ago

Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates

Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update

Business Wire

2 months ago

Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update

Nuvation Bio to Present at The Citizens Life Sciences Conference

Business Wire

2 months ago

Nuvation Bio to Present at The Citizens Life Sciences Conference

Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025

Business Wire

2 months ago

Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025

Is Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Insider Monkey

2 months ago

Is Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Insider Monkey

2 months ago

Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple

Insider Monkey

2 months ago

Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 04/09/2025

Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference

Business Wire

3 months ago

Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference

Business Wire

3 months ago

Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025

Insider Stock Buying Reaches US$720.1k On Nuvation Bio

Simply Wall St.

3 months ago

Insider Stock Buying Reaches US$720.1k On Nuvation Bio

Business Wire

3 months ago

Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025

Is Nuvation Bio Inc. (NYSE:NUVB) the Most Oversold Penny Stocks to Buy According to Analysts?

Insider Monkey

3 months ago

Is Nuvation Bio Inc. (NYSE:NUVB) the Most Oversold Penny Stocks to Buy According to Analysts?

Nuvation Bio Inc. (NUVB): Among the Best NYSE Penny Stocks to Buy According to Analysts

Insider Monkey

4 months ago

Nuvation Bio Inc. (NUVB): Among the Best NYSE Penny Stocks to Buy According to Analysts

Business Wire

4 months ago

Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Nuvation Bio secures $250m for taletrectinib commercialisation

Pharmaceutical Technology

4 months ago

Nuvation Bio secures $250m for taletrectinib commercialisation

MT Newswires

4 months ago

Nuvation Bio to Receive Up to $250 Million in Funding From Sagard Healthcare Partners

Business Wire

4 months ago

Nuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners

Business Wire

4 months ago

Nuvation Bio to Present at the TD Cowen 45th Annual Health Care Conference

MT Newswires

5 months ago

Nuvation Bio Starts Expanded Access Program for Lung Cancer Drug

Business Wire

5 months ago

Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer

With 46% stake, Nuvation Bio Inc. (NYSE:NUVB) seems to have captured institutional investors' interest

Simply Wall St.

5 months ago

With 46% stake, Nuvation Bio Inc. (NYSE:NUVB) seems to have captured institutional investors' interest

MT Newswires

6 months ago

RBC Raises Price Target on Nuvation Bio to $10 From $6, Keeps Outperform, Speculative Risk

Business Wire

6 months ago

Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MT Newswires

6 months ago

Nuvation Bio's Taletrectinib Secures Approval in China for Lung Cancer Treatment

Business Wire

6 months ago

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer

Why Is Nuvation Bio (NUVB) the Best Biotech Penny Stock to Invest in Now?

Insider Monkey

6 months ago

Why Is Nuvation Bio (NUVB) the Best Biotech Penny Stock to Invest in Now?

MT Newswires

6 months ago

Sector Update: Health Care Stocks Fall Premarket Monday

MT Newswires

6 months ago

Nuvation Bio's Lung Cancer Drug Candidate Taletrectinib Gets FDA Priority Review

Business Wire

6 months ago

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PR Newswire

6 months ago

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Business Wire

7 months ago

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference

Nuvation Bio to Present at the Jefferies London Healthcare Conference

Business Wire

7 months ago

Nuvation Bio to Present at the Jefferies London Healthcare Conference

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

Business Wire

8 months ago

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline

Insider Monkey

8 months ago

Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline

Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds?

Insider Monkey

8 months ago

Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds?

Robert Mashal At Nuvation Bio Tops Up Holding By US$220k

Simply Wall St.

8 months ago

Robert Mashal At Nuvation Bio Tops Up Holding By US$220k

Is Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock?

Insider Monkey

8 months ago

Is Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock?

Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35

Insider Monkey

9 months ago

Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35

MT Newswires

9 months ago

Nuvation Bio Names Philippe Sauvage CFO

Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer

Business Wire

9 months ago

Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer

Navigating Legal Uncertainty: Nuvation Bio Inc.’s Chinese Operations and the Shifting Landscape of China’s Civil Law System

TipRanks

9 months ago

Navigating Legal Uncertainty: Nuvation Bio Inc.’s Chinese Operations and the Shifting Landscape of China’s Civil Law System

Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024

Business Wire

9 months ago

Positive Pooled Data from Nuvation Bio’s TRUST-I and TRUST-II Studies Highlight Taletrectinib’s Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024

Nuvation Bio to Present at the Cantor Global Healthcare Conference

Business Wire

10 months ago

Nuvation Bio to Present at the Cantor Global Healthcare Conference

With 47% stake, Nuvation Bio Inc. (NYSE:NUVB) seems to have captured institutional investors' interest

Simply Wall St.

10 months ago

With 47% stake, Nuvation Bio Inc. (NYSE:NUVB) seems to have captured institutional investors' interest

Nuvation Bio pauses oncology drug after Phase I efficacy and safety analysis

Clinical Trials Arena

a year ago

Nuvation Bio pauses oncology drug after Phase I efficacy and safety analysis

Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data

Benzinga

a year ago

Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data

Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update

Business Wire

a year ago

Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update

Nuvation Bio Announces Updates and Upcoming Presentations for its ROS1 Inhibitor, Taletrectinib

Business Wire

a year ago

Nuvation Bio Announces Updates and Upcoming Presentations for its ROS1 Inhibitor, Taletrectinib

We Think Nuvation Bio (NYSE:NUVB) Can Easily Afford To Drive Business Growth

Simply Wall St.

a year ago

We Think Nuvation Bio (NYSE:NUVB) Can Easily Afford To Drive Business Growth

MT Newswires

a year ago

Nuvation Bio Insider Bought Shares Worth $500,089, According to a Recent SEC Filing

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

a year ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

a year ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

a year ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

a year ago

3 Mistakes That Can Get Your Costco Membership Canceled

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Investor's Business Daily

a year ago

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Business Wire

a year ago

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

Investor's Business Daily

a year ago

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EnviroGold Global Closes First Tranche of Private Placement

GlobeNewswire

a year ago

EnviroGold Global Closes First Tranche of Private Placement

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

GuruFocus.com

a year ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

How markets digested hot jobs print: Top takeaways

Yahoo Finance Video

a year ago

How markets digested hot jobs print: Top takeaways

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

PR Newswire

a year ago

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire

a year ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting

Business Wire

a year ago

Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting

Nuvation Bio to Present at the Jefferies Global Healthcare Conference

Business Wire

a year ago

Nuvation Bio to Present at the Jefferies Global Healthcare Conference

MT Newswires

a year ago

Nuvation Bio Q1 Loss Narrows; Shares Fall After Hours

Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update

Business Wire

a year ago

Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update

Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Business Wire

a year ago

Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Nuvation Bio Completes Acquisition of AnHeart Therapeutics

Business Wire

a year ago

Nuvation Bio Completes Acquisition of AnHeart Therapeutics

Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer

Business Wire

a year ago

Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer

Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction

Business Wire

a year ago

Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction

Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors

Business Wire

a year ago

Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors

Nuvation Bio Inc. (NUVB) Is Up 25.28% in One Week: What You Should Know

Zacks

a year ago

Nuvation Bio Inc. (NUVB) Is Up 25.28% in One Week: What You Should Know

Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Business Wire

a year ago

Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

12 Best Medical Stocks to Buy Under $10

Insider Monkey

a year ago

12 Best Medical Stocks to Buy Under $10

Owning 46% shares,institutional owners seem interested in Nuvation Bio Inc. (NYSE:NUVB),

Simply Wall St.

a year ago

Owning 46% shares,institutional owners seem interested in Nuvation Bio Inc. (NYSE:NUVB),

Chuy’s Holdings, Inc. to Announce Fourth Quarter and Fiscal Year 2023 Results on February 22, 2024

GlobeNewswire

a year ago

Chuy’s Holdings, Inc. to Announce Fourth Quarter and Fiscal Year 2023 Results on February 22, 2024

Atlanticus Prices $50 Million Offering of Senior Notes

GlobeNewswire

a year ago

Atlanticus Prices $50 Million Offering of Senior Notes

Horizon Bancorp Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

a year ago

Horizon Bancorp Full Year 2023 Earnings: Misses Expectations

Peapack Gladstone Financial Corp (PGC) Reports Fourth Quarter Earnings Amid Economic Challenges

GuruFocus.com

a year ago

Peapack Gladstone Financial Corp (PGC) Reports Fourth Quarter Earnings Amid Economic Challenges

WSFS Reports 4Q 2023 EPS of $1.05 and ROA of 1.25%;
Reflects Strong Deposit and Fee Revenue Growth, NIM of 3.99%;
Full Year EPS of $4.40 and ROA of 1.33%

Business Wire

a year ago

WSFS Reports 4Q 2023 EPS of $1.05 and ROA of 1.25%; Reflects Strong Deposit and Fee Revenue Growth, NIM of 3.99%; Full Year EPS of $4.40 and ROA of 1.33%

Share on Social Networks: